6151 Helical bundle domain in S46 peptidase
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Organic acids and derivatives | 5 | 0.9 | 5.46× | not tested | |
| Organic nitrogen compounds | 1 | 0.2 | 5.30× | not tested | |
| Benzenoids | 1 | 0.4 | 2.31× | not tested | |
| Homogeneous non-metal compounds | 2 | 1.3 | 1.57× | not tested | |
| Organoheterocyclic compounds | 1 | 0.9 | 1.10× | not tested | |
| Organic oxygen compounds | 1 | 1.2 | 0.85× | not tested | |
| Homogeneous metal compounds | 2 | 2.9 | 0.69× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00161 | VAL | Valine | 14 |
| DB00135 | TYR | Tyrosine | 12 |
| DB00125 | ARG | Arginine | 6 |
| DB00149 | LEU | Leucine | 4 |
| DB00128 | ASP | Aspartic acid | 3 |
| DB00142 | GLU | Glutamic acid | 3 |
| DB00120 | PHE | Phenylalanine | 2 |
| DB00174 | ASN | Asparagine | 2 |
| DB02884 | ALC | 3-Cyclohexyl-L-alanine | 2 |
| DB04349 | PGO | (S)-propane-1,2-diol | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| ZNmetal | ZINC ION | 33 |
| CL | CHLORIDE ION | 17 |
| VAL | VALINE | 14 |
| TYR | TYROSINE | 8 |
| ARG | ARGININE | 6 |
| LEU | LEUCINE | 4 |
| 2L1 | 2-[(4-methyl-1H-imidazol-5-yl)methyl]-1,2,3,4-tetrahydroisoquinoline | 2 |
| ALC | 2-AMINO-3-CYCLOHEXYL-PROPIONIC ACID | 2 |
| ASN | ASPARAGINE | 2 |
| GLU | GLUTAMIC ACID | 2 |
| I87 | (2S)-N,2-dimethyl-N-(propan-2-yl)morpholine-4-sulfonamide | 2 |
| I8A | N-(cyclopropylmethyl)-2,2,3,3-tetramethylazetidine-1-carboxamide | 2 |
| I8D | (4-chlorophenyl)(thiomorpholin-4-yl)methanone | 2 |
| I8G | 2-(4-fluorophenoxy)-1-(pyrrolidin-1-yl)ethan-1-one | 2 |
| I8J | 5-fluoro-1-(1-methylcyclopropane-1-sulfonyl)-1,2,3,6-tetrahydropyridine | 2 |
| K0G | N-phenyl-N'-pyridin-3-ylurea | 2 |
| NT7 | N-(2,3-dimethylphenyl)-2-(morpholin-4-yl)acetamide | 2 |
| NU4 | 2-methyl-N-(pyridin-4-yl)furan-3-carboxamide | 2 |
| O2A | N-methyl-1H-indole-7-carboxamide | 2 |
| PHE | PHENYLALANINE | 2 |